Bioline Rx Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 39.00 K | $120.90 K | 282.35% | 0.88% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 30.91 K | $95.82 K | 100.00% | 0.70% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 15.41 K | $48.09 K | 100.00% | 0.35% |
| CITADEL ADVISORS LLC | 09/02/2026 | 14.80 K | $45.87 K | 100.00% | 0.33% |
| RHUMBLINE ADVISERS | 08/12/2026 | 2.48 K | $7.68 K | 5.31% | 0.06% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 2.00 K | $6.24 K | 14.29% | 0.05% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 500 | $1.55 K | -72.22% | 0.01% |
| NEMES RUSH GROUP LLC | 08/14/2026 | 250 | $780 | 0.00% | 0.01% |
| UBS GROUP AG | 08/13/2026 | 101 | $315 | -80.91% | 0.00% |
| NEWEDGE ADVISORS, LLC | 08/12/2026 | 82 | $256 | -23.36% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 26 | $81 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 10 | $31 | 100.00% | 0.00% |
| DANSKE BANK A/S | 08/10/2026 | 2 | $6 | 0.00% | 0.00% |
| BANQUE CANTONALE VAUDOISE | 07/31/2026 | 1 | $1.00 K | 100.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 1 | $3 | -99.94% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bioline Rx Ltd institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Bioline Rx Ltd. The most heavily invested institutionals were:
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 30,911
RENAISSANCE TECHNOLOGIES LLC: 15,412
CITADEL ADVISORS LLC: 14,796
RHUMBLINE ADVISERS: 2,478
WELLS FARGO & COMPANY/MN: 2,000
BNP PARIBAS ARBITRAGE, SNC: 500
1.50% of Bioline Rx Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 895.67 K shares in the last 24 months. This purchase volume represents approximately $2.37 M in transactions.